Jordans' anomaly: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Jordans' anomaly | |||
| image = [[File:Chanarin-Dorfman_Syndrome_smear_2009-11-13.JPG|thumb|Blood smear showing Jordans' anomaly]] | |||
| caption = Blood smear showing Jordans' anomaly | |||
| field = [[Hematology]] | |||
| synonyms = Neutral lipid storage disease with ichthyosis | |||
| symptoms = [[Ichthyosis]], lipid vacuoles in [[leukocytes]] | |||
| complications = [[Hepatomegaly]], [[splenomegaly]], [[myopathy]] | |||
| onset = Congenital | |||
| duration = Lifelong | |||
| causes = Genetic mutation in the [[ABHD5]] gene | |||
| risks = Family history | |||
| diagnosis = [[Blood smear]], genetic testing | |||
| differential = [[Chanarin-Dorfman syndrome]], other lipid storage disorders | |||
| treatment = Symptomatic management, dietary modifications | |||
| medication = None specific | |||
| prognosis = Variable, depends on severity | |||
| frequency = Rare | |||
}} | |||
'''Jordan's Anomaly''' is a rare [[hematological disorder]] characterized by the presence of abnormally large [[platelets]] in the blood and a mild to moderate reduction in platelet count, a condition known as [[macrothrombocytopenia]]. This anomaly is often discovered incidentally during routine blood tests and is usually asymptomatic, although it may be associated with a slightly increased risk of bleeding. | '''Jordan's Anomaly''' is a rare [[hematological disorder]] characterized by the presence of abnormally large [[platelets]] in the blood and a mild to moderate reduction in platelet count, a condition known as [[macrothrombocytopenia]]. This anomaly is often discovered incidentally during routine blood tests and is usually asymptomatic, although it may be associated with a slightly increased risk of bleeding. | ||
==Etiology== | ==Etiology== | ||
The exact cause of Jordan's Anomaly is not well understood, but it is believed to be primarily genetic. It has been observed to occur in families, suggesting a hereditary component. However, specific genetic mutations or patterns have not been fully elucidated. | The exact cause of Jordan's Anomaly is not well understood, but it is believed to be primarily genetic. It has been observed to occur in families, suggesting a hereditary component. However, specific genetic mutations or patterns have not been fully elucidated. | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of Jordan's Anomaly is primarily based on blood tests, particularly a [[Complete Blood Count]] (CBC) with a platelet count and blood smear examination. The hallmark of the condition is the presence of large platelets on the blood smear, often with a mild decrease in the overall number of platelets. Further hematological tests may be conducted to rule out other causes of macrothrombocytopenia. | Diagnosis of Jordan's Anomaly is primarily based on blood tests, particularly a [[Complete Blood Count]] (CBC) with a platelet count and blood smear examination. The hallmark of the condition is the presence of large platelets on the blood smear, often with a mild decrease in the overall number of platelets. Further hematological tests may be conducted to rule out other causes of macrothrombocytopenia. | ||
==Clinical Significance== | ==Clinical Significance== | ||
In most cases, Jordan's Anomaly is an incidental finding and does not lead to significant health problems. However, individuals with this condition may have a slightly increased risk of bleeding, especially after surgery or injury. It is important for patients diagnosed with Jordan's Anomaly to inform their healthcare providers of their condition before undergoing any medical procedures. | In most cases, Jordan's Anomaly is an incidental finding and does not lead to significant health problems. However, individuals with this condition may have a slightly increased risk of bleeding, especially after surgery or injury. It is important for patients diagnosed with Jordan's Anomaly to inform their healthcare providers of their condition before undergoing any medical procedures. | ||
==Management== | ==Management== | ||
Since Jordan's Anomaly is typically asymptomatic and does not significantly affect health, specific treatment is usually not required. Management focuses on monitoring the condition and addressing any complications, such as bleeding, should they arise. Patients are advised to avoid medications that can further increase bleeding risk, such as nonsteroidal anti-inflammatory drugs (NSAIDs). | Since Jordan's Anomaly is typically asymptomatic and does not significantly affect health, specific treatment is usually not required. Management focuses on monitoring the condition and addressing any complications, such as bleeding, should they arise. Patients are advised to avoid medications that can further increase bleeding risk, such as nonsteroidal anti-inflammatory drugs (NSAIDs). | ||
==See Also== | ==See Also== | ||
* [[Platelet]] | * [[Platelet]] | ||
| Line 18: | Line 33: | ||
* [[Hematological disorder]] | * [[Hematological disorder]] | ||
* [[Complete Blood Count]] | * [[Complete Blood Count]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Blood disorders]] | [[Category:Blood disorders]] | ||
{{Med-stub}} | {{Med-stub}} | ||
Latest revision as of 03:31, 6 April 2025

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Jordans' anomaly | |
|---|---|
| Synonyms | Neutral lipid storage disease with ichthyosis |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Ichthyosis, lipid vacuoles in leukocytes |
| Complications | Hepatomegaly, splenomegaly, myopathy |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation in the ABHD5 gene |
| Risks | Family history |
| Diagnosis | Blood smear, genetic testing |
| Differential diagnosis | Chanarin-Dorfman syndrome, other lipid storage disorders |
| Prevention | N/A |
| Treatment | Symptomatic management, dietary modifications |
| Medication | None specific |
| Prognosis | Variable, depends on severity |
| Frequency | Rare |
| Deaths | N/A |
Jordan's Anomaly is a rare hematological disorder characterized by the presence of abnormally large platelets in the blood and a mild to moderate reduction in platelet count, a condition known as macrothrombocytopenia. This anomaly is often discovered incidentally during routine blood tests and is usually asymptomatic, although it may be associated with a slightly increased risk of bleeding.
Etiology[edit]
The exact cause of Jordan's Anomaly is not well understood, but it is believed to be primarily genetic. It has been observed to occur in families, suggesting a hereditary component. However, specific genetic mutations or patterns have not been fully elucidated.
Diagnosis[edit]
Diagnosis of Jordan's Anomaly is primarily based on blood tests, particularly a Complete Blood Count (CBC) with a platelet count and blood smear examination. The hallmark of the condition is the presence of large platelets on the blood smear, often with a mild decrease in the overall number of platelets. Further hematological tests may be conducted to rule out other causes of macrothrombocytopenia.
Clinical Significance[edit]
In most cases, Jordan's Anomaly is an incidental finding and does not lead to significant health problems. However, individuals with this condition may have a slightly increased risk of bleeding, especially after surgery or injury. It is important for patients diagnosed with Jordan's Anomaly to inform their healthcare providers of their condition before undergoing any medical procedures.
Management[edit]
Since Jordan's Anomaly is typically asymptomatic and does not significantly affect health, specific treatment is usually not required. Management focuses on monitoring the condition and addressing any complications, such as bleeding, should they arise. Patients are advised to avoid medications that can further increase bleeding risk, such as nonsteroidal anti-inflammatory drugs (NSAIDs).